Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.39491675
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

25.65 -0.04 (-0.16%)

78.12% Gain from 52W Low

675.5K

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.7 / 100

Technically Neutral

49.1 / 100

1Yr Price target upside is 108%

14 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

78.12% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart